SHL Telemedicine Ltd. (SHLT)
USD 3.02
(-13.69%)
USD 3.02
(-13.69%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 13.15 Million USD | -40.89% |
| 2022 | 22.25 Million USD | 26.07% |
| 2021 | 17.65 Million USD | 69.35% |
| 2020 | 10.42 Million USD | 68.16% |
| 2019 | 6.2 Million USD | 277.35% |
| 2018 | -3.49 Million USD | -140.08% |
| 2017 | 8.72 Million USD | -50.42% |
| 2016 | 17.59 Million USD | 11.4% |
| 2015 | 15.79 Million USD | -20.33% |
| 2014 | 19.82 Million USD | -0.63% |
| 2013 | 19.95 Million USD | 12.17% |
| 2012 | 17.78 Million USD | 21.25% |
| 2011 | 14.66 Million USD | 6038.87% |
| 2010 | -247 Thousand USD | 0.0% |
| 2009 | - USD | 100.0% |
| 2008 | -3.26 Million USD | 90.53% |
| 2007 | -34.47 Million USD | -153.65% |
| 2006 | 64.26 Million USD | 373.07% |
| 2005 | 13.58 Million USD | -48.42% |
| 2004 | 26.33 Million USD | 247.89% |
| 2003 | -17.8 Million USD | 51.36% |
| 2002 | -36.6 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 252 Thousand USD | 2686.11% |
| 2024 Q1 | 252 Thousand USD | -98.08% |
| 2023 Q1 | 11.83 Million USD | -46.84% |
| 2023 Q3 | 10.73 Million USD | -24.59% |
| 2023 Q4 | 13.15 Million USD | 22.62% |
| 2023 FY | 13.15 Million USD | -40.89% |
| 2023 Q2 | 14.23 Million USD | 20.26% |
| 2022 Q1 | 9.23 Million USD | -47.7% |
| 2022 Q3 | 19.99 Million USD | 75.05% |
| 2022 Q4 | 22.25 Million USD | 11.32% |
| 2022 FY | 22.25 Million USD | 26.07% |
| 2022 Q2 | 11.42 Million USD | 23.71% |
| 2021 Q4 | 17.65 Million USD | 15.29% |
| 2021 Q2 | -12.39 Million USD | 11.58% |
| 2021 Q1 | -14.01 Million USD | -234.39% |
| 2021 FY | 17.65 Million USD | 69.35% |
| 2021 Q3 | 15.31 Million USD | 223.61% |
| 2020 Q1 | 7.87 Million USD | 27.06% |
| 2020 Q4 | 10.42 Million USD | 18.33% |
| 2020 Q2 | 9.05 Million USD | 14.98% |
| 2020 FY | 10.42 Million USD | 68.16% |
| 2020 Q3 | 8.81 Million USD | -2.73% |
| 2019 Q3 | 4.87 Million USD | 11188.64% |
| 2019 Q1 | -359 Thousand USD | 89.73% |
| 2019 Q2 | -44 Thousand USD | 87.74% |
| 2019 FY | 6.2 Million USD | 277.35% |
| 2019 Q4 | 6.2 Million USD | 27.08% |
| 2018 Q1 | 7.81 Million USD | -10.42% |
| 2018 FY | -3.49 Million USD | -140.08% |
| 2018 Q4 | -3.49 Million USD | 0.0% |
| 2018 Q3 | -3.49 Million USD | -144.74% |
| 2018 Q2 | 7.81 Million USD | 0.0% |
| 2017 FY | 8.72 Million USD | -50.42% |
| 2017 Q2 | 6.68 Million USD | 0.0% |
| 2017 Q1 | 6.68 Million USD | -62.02% |
| 2017 Q4 | 8.72 Million USD | 0.0% |
| 2017 Q3 | 8.72 Million USD | 30.54% |
| 2016 Q1 | 17.1 Million USD | 8.3% |
| 2016 FY | 17.59 Million USD | 11.4% |
| 2016 Q4 | 17.59 Million USD | 0.0% |
| 2016 Q3 | 17.59 Million USD | 2.86% |
| 2016 Q2 | 17.1 Million USD | 0.0% |
| 2015 Q2 | 14.1 Million USD | -16.81% |
| 2015 Q1 | 16.95 Million USD | -14.48% |
| 2015 Q4 | 15.79 Million USD | 0.0% |
| 2015 FY | 15.79 Million USD | -20.33% |
| 2015 Q3 | 15.79 Million USD | 11.98% |
| 2014 Q2 | 18.98 Million USD | -14.91% |
| 2014 Q1 | 22.31 Million USD | 11.84% |
| 2014 FY | 19.82 Million USD | -0.63% |
| 2014 Q4 | 19.82 Million USD | -1.22% |
| 2014 Q3 | 20.06 Million USD | 5.7% |
| 2013 Q4 | 19.95 Million USD | -0.25% |
| 2013 FY | 19.95 Million USD | 12.17% |
| 2013 Q1 | 15.05 Million USD | -15.33% |
| 2013 Q2 | 18.62 Million USD | 23.68% |
| 2013 Q3 | 20 Million USD | 7.38% |
| 2012 Q2 | 12.17 Million USD | -22.8% |
| 2012 Q4 | 17.78 Million USD | 23.76% |
| 2012 FY | 17.78 Million USD | 21.25% |
| 2012 Q1 | 15.76 Million USD | 7.5% |
| 2012 Q3 | 14.37 Million USD | 18.05% |
| 2011 Q3 | 26.54 Million USD | 482.98% |
| 2011 Q2 | 4.55 Million USD | 224.98% |
| 2011 Q1 | 1.4 Million USD | 667.21% |
| 2011 FY | 14.66 Million USD | 6038.87% |
| 2011 Q4 | 14.66 Million USD | -44.73% |
| 2010 Q4 | -247 Thousand USD | 85.2% |
| 2010 Q1 | -310 Thousand USD | 0.0% |
| 2010 Q2 | -3 Million USD | -867.74% |
| 2010 Q3 | -1.66 Million USD | 44.37% |
| 2010 FY | -247 Thousand USD | 0.0% |
| 2009 FY | - USD | 100.0% |
| 2009 Q2 | -6.61 Million USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 FY | -3.26 Million USD | 90.53% |
| 2007 FY | -34.47 Million USD | -153.65% |
| 2006 FY | 64.26 Million USD | 373.07% |
| 2005 FY | 13.58 Million USD | -48.42% |
| 2004 FY | 26.33 Million USD | 247.89% |
| 2003 FY | -17.8 Million USD | 51.36% |
| 2002 FY | -36.6 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 773.42 Million USD | 98.299% |
| GE HealthCare Technologies Inc. | 7.36 Billion USD | 99.821% |
| Sharecare, Inc. | -125.84 Million USD | 110.456% |
| Progyny, Inc. | -77.9 Million USD | 116.89% |
| Aclarion, Inc. | 94.65 Thousand USD | -13801.091% |
| CareMax, Inc. | 426.4 Million USD | 96.914% |
| Simulations Plus, Inc. | -9.83 Million USD | 233.775% |
| CareCloud, Inc. | 11.4 Million USD | -15.401% |
| Forian Inc. | 16.95 Million USD | 22.411% |
| Bullfrog AI Holdings, Inc. Warrants | -2.62 Million USD | 601.312% |
| Bullfrog AI Holdings, Inc. Common Stock | -2.62 Million USD | 601.312% |
| Minerva Surgical, Inc. | 32.74 Million USD | 59.82% |
| Omnicell, Inc. | 113.11 Million USD | 88.367% |
| Definitive Healthcare Corp. | 136.95 Million USD | 90.392% |
| Zhongchao Inc. | -6.74 Million USD | 295.208% |
| Accolade, Inc. | 55.93 Million USD | 76.474% |
| Streamline Health Solutions, Inc. | 7.37 Million USD | -78.39% |
| Ontrak, Inc. | -8.01 Million USD | 264.23% |
| SOPHiA GENETICS SA | -104.65 Million USD | 112.573% |
| R1 RCM Inc. | 1.56 Billion USD | 99.16% |
| Spok Holdings, Inc. | -20.9 Million USD | 162.948% |
| Privia Health Group, Inc. | -381.22 Million USD | 103.452% |
| EUDA Health Holdings Limited | 3.18 Million USD | -313.059% |
| HeartBeam, Inc. | -16.18 Million USD | 181.278% |
| GeneDx Holdings Corp. | 20.08 Million USD | 34.501% |
| TruBridge, Inc. | 199.44 Million USD | 93.403% |
| Nutex Health, Inc. | 253.75 Million USD | 94.815% |
| Renalytix Plc | 3.85 Million USD | -241.325% |
| Sharecare, Inc. | -125.84 Million USD | 110.456% |
| Health Catalyst, Inc. | 142.79 Million USD | 90.785% |
| 10x Genomics, Inc. | -263.91 Million USD | 104.986% |
| GoodRx Holdings, Inc. | 38.77 Million USD | 66.065% |
| SCWorx Corp. | -1077.00 USD | 1221834.262% |
| Schrödinger, Inc. | -33.18 Million USD | 139.652% |
| HealthEquity, Inc. | 529.16 Million USD | 97.513% |
| HealthStream, Inc. | -17.11 Million USD | 176.894% |
| MSP Recovery, Inc. | 667.69 Million USD | 98.029% |
| Augmedix, Inc. | -20.49 Million USD | 164.198% |
| BrightSpring Health Services, Inc. Common Stock | 3.65 Billion USD | 99.64% |
| Ontrak, Inc. | -8.01 Million USD | 264.23% |
| CareCloud, Inc. | 11.4 Million USD | -15.401% |
| Premier, Inc. | 855 Thousand USD | -1438.956% |
| Certara, Inc. | 63.24 Million USD | 79.194% |
| GeneDx Holdings Corp. | 20.08 Million USD | 34.501% |
| OneMedNet Corporation | 5.05 Million USD | -160.334% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.65 Billion USD | 99.64% |
| EUDA Health Holdings Limited | 3.18 Million USD | -313.059% |
| HeartBeam, Inc. | -16.18 Million USD | 181.278% |
| CareCloud, Inc. | 11.4 Million USD | -15.401% |
| Mangoceuticals, Inc. | -610.32 Thousand USD | 2255.903% |
| CareMax, Inc. | 426.4 Million USD | 96.914% |
| Healthcare Triangle, Inc. | 3.08 Million USD | -326.795% |
| National Research Corporation | 32.3 Million USD | 59.267% |
| Aclarion, Inc. | 94.65 Thousand USD | -13801.091% |
| OptimizeRx Corporation | 22.97 Million USD | 42.72% |